Blog

Nov 4, 2024, 15:41

Updates on the Breast Cancer Working Group – IMMONC

Immune Oncology Research Institute (IMMONC) posted on LinkedIn:

“Updates on the Breast Cancer Working Group
In 2024, three multidisciplinary team (MDT) meetings focused on breast cancer have taken place, with a fourth scheduled for December. During these sessions, seven new cases were reviewed, and updates on active clinical trials in breast cancer were shared.

Led by Dr. Liana Safaryan from the Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, the team examines challenging breast cancer cases. The discussions are supported by Dr. Nathaniel Boughanim, Dr. Sarkis Meterissian, and Dr. Tarek Hijal from McGill University in Canada.

In addition to real case reviews, the group explores case simulations and hypothetical scenarios, focusing on tumor histotypes and the latest advancements in the field.”

Read Further.

Breast Cancer cancer Immune Oncology Research Institute Liana Safaryan Nathaniel Boughanim OncoDaily Oncology Sarkis Meterissian Tarek Hijal Yeolyan Hematology and Oncology Center

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage